Transfusion Medicine Reviews
Volume 18, Issue 1 , Pages 25-35, January 2004

Review of the quality monitoring methods used by countries using or implementing universal leukoreduction

  • Neil Beckman

      Affiliations

    • Birmingham Blood Center, National Blood Service, Birmingham, United Kingdom
    • Corresponding Author InformationAddress reprint requests to Neil Beckman, Birmingham Blood Center, National Blood Service, Vincent Drive, Edgbaston, Birmingham B15 2SG, United Kingdom
  • ,
  • Graham Sher

      Affiliations

    • Birmingham Blood Center, National Blood Service, Birmingham, United Kingdom
  • ,
  • Maurice Masse

      Affiliations

    • Birmingham Blood Center, National Blood Service, Birmingham, United Kingdom
  • ,
  • Ekkehard Richter

      Affiliations

    • Birmingham Blood Center, National Blood Service, Birmingham, United Kingdom
  • ,
  • Juergen Ringwald

      Affiliations

    • Birmingham Blood Center, National Blood Service, Birmingham, United Kingdom
  • ,
  • Paolo Rebulla

      Affiliations

    • Birmingham Blood Center, National Blood Service, Birmingham, United Kingdom
  • ,
  • Pieter van Der Meer

      Affiliations

    • Birmingham Blood Center, National Blood Service, Birmingham, United Kingdom
  • ,
  • Benvindo Justica

      Affiliations

    • Birmingham Blood Center, National Blood Service, Birmingham, United Kingdom
  • ,
  • Brian Walker

      Affiliations

    • Birmingham Blood Center, National Blood Service, Birmingham, United Kingdom
  • ,
  • Graham Rowe

      Affiliations

    • Birmingham Blood Center, National Blood Service, Birmingham, United Kingdom
  • ,
  • BEST Working Party of the ISBT

      Affiliations

    • Birmingham Blood Center, National Blood Service, Birmingham, United Kingdom

Abstract 

Several countries are implementing or have implemented universal leukoreduction (ULR). Specifications, leukocyte counting, and monitoring methods were essential elements in achieving process confidence and conformance. A review of these protocols is presented. A questionnaire was prepared, agreed, and circulated, and responses were collated. Different specifications have been adopted as well as disparate approaches to leukocyte counting and residual leukocyte monitoring. Parametric, nonparametric, and pass-rate methods of analysis were used. Despite these differences, users were satisfied that the methodologies were providing assurance of component quality.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-7963(03)00069-5

doi:10.1016/j.tmrv.2003.10.007

Transfusion Medicine Reviews
Volume 18, Issue 1 , Pages 25-35, January 2004